The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

Formulatrix, a leader in laboratory automation solutions, and Spear Bio, an innovator in ultrasensitive protein biomarker ...

Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) ...

Objectives Understanding the molecular changes in the preclinical synovium is crucial for identifying factors that drive ...

The most successful players — both old and new — are those focusing on operational risk control rather than assay novelty.

Mira is bringing its version of Oxford Cancer Biomarkers' PGx test to the US in the newly launched ToxNav Advantage assay.